Lorena Lucatello
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lorena Lucatello has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Manlio Palumbo
University of Padova
8 shared publications - Petra Cagnardi
Department of Veterinary Medicine and Animal Sciences, University of Milan, Via dell’Università 6, 26900 Lodi, Italy
6 shared publications Francesca Capolongo
5 shared publications- Francesca Capolongo
Department of Comparative Biomedicine and Food Science, University of Padova, Legnaro, Italy
5 shared publications Vittoria Bisutti
5 shared publicationsClaudia Sissi
4 shared publications
Latest Publications
- Open Access
- 24 October 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
A Novel Application of the Volumetric Absorptive Micro Sampling Strategy to Quantify Dexmedetomidine in Capillary Blood Using an LC – MS / MS Method
Background: Pain control in neonates is crucial as inadequate management may impair neuronal development. Dexmedetomidine (DEX), an alpha2 agonist, is approved for intravenous use in ventilated neonates. While intranasal DEX is off‐label in neonates and children, studies show its efficacy for magnetic resonance imaging sedation. Limited pharmacokinetic data exist for intranasal DEX in pre‐term infants and neonates. This study aimed to develop an analytical method for DEX quantification in blood samples (20 μL) of complex patients collected with microsampling technique to enable future pharmacokinetic studies. Methods: A liquid–liquid extraction from blood absorbed in microsampling devices (MITRA) and an LC–MS/MS method were developed and validated following EMA/FDA guidelines. The method's suitability was verified by comparing results from nine paediatric blood samples collected in EDTA tubes or using MITRA devices. Results: All results obtained for selectivity (no interference at R T of DEX), sensitivity (DEX LLOQ = 0.025 ng/mL), linearity (R 2 > 0.99), intra and inter‐day repeatability (CV % 1.8–11.8), stability, and hematocrit effect met the acceptance criteria for bioanalytical method validation. Compared with plasma samples, the proposed method showed good consistency in detecting DEX in MITRA samples. Conclusion: The MITRA microsampling tools reduce the amount of blood needed and the risks of anemisation for neonates hospitalised and simplifies procedures, allowing a reduction of the staff involved in the routine. The analytical and clinical validation of the method demonstrated its suitability to quantify DEX in a range of concentrations potentially useful for pharmacokinetic studies in paediatric patients for approval use and drug monitoring.
- 24 October 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
Open AccessA Novel Application of the Volumetric Absorptive Micro Sampling Strategy to Quantify Dexmedetomidine in Capillary Blood Using an LC – MS / MS Method
Background: Pain control in neonates is crucial as inadequate management may impair neuronal development. Dexmedetomidine (DEX), an alpha2 agonist, is approved for intravenous use in ventilated neonates. While intranasal DEX is off‐label in neonates and children, studies show its efficacy for magnetic resonance imaging sedation. Limited pharmacokinetic data exist for intranasal DEX in pre‐term infants and neonates. This study aimed to develop an analytical method for DEX quantification in blood samples (20 μL) of complex patients collected with microsampling technique to enable future pharmacokinetic studies. Methods: A liquid–liquid extraction from blood absorbed in microsampling devices (MITRA) and an LC–MS/MS method were developed and validated following EMA/FDA guidelines. The method's suitability was verified by comparing results from nine paediatric blood samples collected in EDTA tubes or using MITRA devices. Results: All results obtained for selectivity (no interference at R T of DEX), sensitivity (DEX LLOQ = 0.025 ng/mL), linearity (R 2 > 0.99), intra and inter‐day repeatability (CV % 1.8–11.8), stability, and hematocrit effect met the acceptance criteria for bioanalytical method validation. Compared with plasma samples, the proposed method showed good consistency in detecting DEX in MITRA samples. Conclusion: The MITRA microsampling tools reduce the amount of blood needed and the risks of anemisation for neonates hospitalised and simplifies procedures, allowing a reduction of the staff involved in the routine. The analytical and clinical validation of the method demonstrated its suitability to quantify DEX in a range of concentrations potentially useful for pharmacokinetic studies in paediatric patients for approval use and drug monitoring.
- 6 November 2023
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 50 (6) , 540
Clinical effects and pharmacokinetics of low-dose butorphanol intravenously in donkeys
- 6 November 2023
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 50 (6) , 540
Clinical effects and pharmacokinetics of low-dose butorphanol intravenously in donkeys
- 1 February 2022
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 50 (1) , 31-40
Development and optimization of a fentanyl pharmacokinetic model for target-controlled infusion in anaesthetized dogs
- 1 February 2022
- Published by Elsevier in Veterinary Anaesthesia and Analgesia
- Vol. 50 (1) , 31-40
Development and optimization of a fentanyl pharmacokinetic model for target-controlled infusion in anaesthetized dogs
- Open Access
- 23 December 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-15
Functional impact of cytochrome P450 3A (CYP3A) missense variants in cattle
Cytochrome P450 3A is the most important CYP subfamily in humans, and CYP3A4/CYP3A5 genetic variants contribute to inter-individual variability in drug metabolism. However, no information is available for bovine CYP3A (bCYP3A). Here we described bCYP3A missense single nucleotide variants (SNVs) and evaluated their functional effects. CYP3A28, CYP3A38 and CYP3A48 missense SNVs were identified in 300 bulls of Piedmontese breed through targeted sequencing. Wild-type and mutant bCYP3A cDNAs were cloned and expressed in V79 cells. CYP3A-dependent oxidative metabolism of testosterone (TST) and nifedipine (NIF) was assessed by LC-MS/MS. Finally, SNVs functional impact on TST hydroxylation was measured ex vivo in liver microsomes from individually genotyped animals. Thirteen missense SNVs were identified and validated. Five variants showed differences in CYP3A catalytic activity: three CYP3A28 SNVs reduced TST 6β-hydroxylation; one CYP3A38 variant increased TST 16β-hydroxylation, while a CYP3A48 SNV showed enhanced NIF oxidation. Individuals homozygous for rs384467435 SNV showed a reduced TST 6β-hydroxylation. Molecular modelling showed that most of SNVs were distal to CYP3A active site, suggesting indirect effects on the catalytic activity. Collectively, these findings demonstrate the importance of pharmacogenetics studies in veterinary species and suggest bCYP3A genotype variation might affect the fate of xenobiotics in food-producing species such as cattle.
- 23 December 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-15
Open AccessFunctional impact of cytochrome P450 3A (CYP3A) missense variants in cattle
Cytochrome P450 3A is the most important CYP subfamily in humans, and CYP3A4/CYP3A5 genetic variants contribute to inter-individual variability in drug metabolism. However, no information is available for bovine CYP3A (bCYP3A). Here we described bCYP3A missense single nucleotide variants (SNVs) and evaluated their functional effects. CYP3A28, CYP3A38 and CYP3A48 missense SNVs were identified in 300 bulls of Piedmontese breed through targeted sequencing. Wild-type and mutant bCYP3A cDNAs were cloned and expressed in V79 cells. CYP3A-dependent oxidative metabolism of testosterone (TST) and nifedipine (NIF) was assessed by LC-MS/MS. Finally, SNVs functional impact on TST hydroxylation was measured ex vivo in liver microsomes from individually genotyped animals. Thirteen missense SNVs were identified and validated. Five variants showed differences in CYP3A catalytic activity: three CYP3A28 SNVs reduced TST 6β-hydroxylation; one CYP3A38 variant increased TST 16β-hydroxylation, while a CYP3A48 SNV showed enhanced NIF oxidation. Individuals homozygous for rs384467435 SNV showed a reduced TST 6β-hydroxylation. Molecular modelling showed that most of SNVs were distal to CYP3A active site, suggesting indirect effects on the catalytic activity. Collectively, these findings demonstrate the importance of pharmacogenetics studies in veterinary species and suggest bCYP3A genotype variation might affect the fate of xenobiotics in food-producing species such as cattle.
- 25 July 2019
- Published by Springer Nature in European Food Research and Technology
- Vol. 245 (10) , 2269-2278
Multivariate and machine learning models to assess the heat effects on honey physicochemical, colour and NIR data
- 25 July 2019
- Published by Springer Nature in European Food Research and Technology
- Vol. 245 (10) , 2269-2278
Multivariate and machine learning models to assess the heat effects on honey physicochemical, colour and NIR data
- 14 June 2019
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 42 (4) , 392-400
Clinical pharmacokinetics of a dexmedetomidine–methadone combination in dogs undergoing routine anaesthesia after buccal or intramuscular administration
This study aimed to define the pharmacokinetic profiles of dexmedetomidine and methadone administered simultaneously in dogs by either an oral transmucosal route or intramuscular route and to determine the bioavailability of the oral transmucosal administration relative to the intramuscular one of both drugs, so as the applicability of this administration route in dogs. Twelve client‐owned dogs, scheduled for diagnostic procedures, were treated with a combination of dexmedetomidine hydrochloride (10 μg/kg) and methadone hydrochloride (0.4 mg/kg) through an oral transmucosal route or intramuscularly. Oral transmucosal administration caused ptyalism in most subjects, and intramuscular administration caused transient peripheral vasoconstriction. The results showed reduced and delayed absorption of both dexmedetomidine and methadone when administered through an oral transmucosal route, with median (range) Cmax values of 0.82 (0.42–1.49) ng/ml and 13.22 (2.80–52.30) ng/ml, respectively. The relative bioavailability was low: 16.34% (dexmedetomidine) and 15.5% (methadone). Intramuscular administration resulted in a more efficient absorption profile, with AUC and Cmax values for both drugs approximately 10 times higher. Dexmedetomidine and methadone administered simultaneously by an oral transmucosal route using injectable formulations were not well absorbed through the oral mucosa. Nevertheless, additional studies on these drugs combination using alternative administration routes are recommended.
- 14 June 2019
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 42 (4) , 392-400
Clinical pharmacokinetics of a dexmedetomidine–methadone combination in dogs undergoing routine anaesthesia after buccal or intramuscular administration
This study aimed to define the pharmacokinetic profiles of dexmedetomidine and methadone administered simultaneously in dogs by either an oral transmucosal route or intramuscular route and to determine the bioavailability of the oral transmucosal administration relative to the intramuscular one of both drugs, so as the applicability of this administration route in dogs. Twelve client‐owned dogs, scheduled for diagnostic procedures, were treated with a combination of dexmedetomidine hydrochloride (10 μg/kg) and methadone hydrochloride (0.4 mg/kg) through an oral transmucosal route or intramuscularly. Oral transmucosal administration caused ptyalism in most subjects, and intramuscular administration caused transient peripheral vasoconstriction. The results showed reduced and delayed absorption of both dexmedetomidine and methadone when administered through an oral transmucosal route, with median (range) Cmax values of 0.82 (0.42–1.49) ng/ml and 13.22 (2.80–52.30) ng/ml, respectively. The relative bioavailability was low: 16.34% (dexmedetomidine) and 15.5% (methadone). Intramuscular administration resulted in a more efficient absorption profile, with AUC and Cmax values for both drugs approximately 10 times higher. Dexmedetomidine and methadone administered simultaneously by an oral transmucosal route using injectable formulations were not well absorbed through the oral mucosa. Nevertheless, additional studies on these drugs combination using alternative administration routes are recommended.
- 15 January 2019
- Published by SAGE Publications in Journal of Near Infrared Spectroscopy
- Vol. 27 (1) , 65-74
Multivariate and machine learning approaches for honey botanical origin authentication using near infrared spectroscopy
In this work the feasibility of near infrared spectroscopy was evaluated combined with chemometric approaches, as a tool for the botanical origin prediction of 119 honey samples. Four varieties related to polyfloral, acacia, chestnut, and linden were first characterized by their physical–chemical parameters and then analyzed in triplicate using a near infrared spectrophotometer equipped with an optical path gold reflector. Three different classifiers were built on distinct multivariate and machine learning approaches for honey botanical classification. A partial least squares discriminant analysis was used as a first approach to build a predictive model for honey classification. Spectra pretreatments named autoscale, standard normal variate, detrending, first derivative, and smoothing were applied for the reduction of scattering related to the presence of particle size, like glucose crystals. The values of the descriptive statistics of the partial least squares discriminant analysis model allowed a sufficient floral group prediction for the acacia and polyfloral honeys but not in the cases of chestnut and linden. The second classifier, based on a support vector machine, allowed a better classification of acacia and polyfloral and also achieved the classification of chestnut. The linden samples instead remained unclassified. A further investigation, aimed to improve the botanical discrimination, exploited a feature selection algorithm named Boruta, which assigned a pool of 39 informative averaged near infrared spectral variables on which a canonical discriminant analysis was assessed. The canonical discriminant analysis accounted a better separation of samples according to the botanical origin than the partial least squares discriminant analysis. The approach used has permitted to achieve a complete authentication of the acacia honeys but not a precise segregation of polyfloral ones. The comparison between the variables important in projection and the Boruta pool showed that the informative wavelengths are partially shared especially in the middle and far band of the near infrared spectral range.
- 15 January 2019
- Published by SAGE Publications in Journal of Near Infrared Spectroscopy
- Vol. 27 (1) , 65-74
Multivariate and machine learning approaches for honey botanical origin authentication using near infrared spectroscopy
In this work the feasibility of near infrared spectroscopy was evaluated combined with chemometric approaches, as a tool for the botanical origin prediction of 119 honey samples. Four varieties related to polyfloral, acacia, chestnut, and linden were first characterized by their physical–chemical parameters and then analyzed in triplicate using a near infrared spectrophotometer equipped with an optical path gold reflector. Three different classifiers were built on distinct multivariate and machine learning approaches for honey botanical classification. A partial least squares discriminant analysis was used as a first approach to build a predictive model for honey classification. Spectra pretreatments named autoscale, standard normal variate, detrending, first derivative, and smoothing were applied for the reduction of scattering related to the presence of particle size, like glucose crystals. The values of the descriptive statistics of the partial least squares discriminant analysis model allowed a sufficient floral group prediction for the acacia and polyfloral honeys but not in the cases of chestnut and linden. The second classifier, based on a support vector machine, allowed a better classification of acacia and polyfloral and also achieved the classification of chestnut. The linden samples instead remained unclassified. A further investigation, aimed to improve the botanical discrimination, exploited a feature selection algorithm named Boruta, which assigned a pool of 39 informative averaged near infrared spectral variables on which a canonical discriminant analysis was assessed. The canonical discriminant analysis accounted a better separation of samples according to the botanical origin than the partial least squares discriminant analysis. The approach used has permitted to achieve a complete authentication of the acacia honeys but not a precise segregation of polyfloral ones. The comparison between the variables important in projection and the Boruta pool showed that the informative wavelengths are partially shared especially in the middle and far band of the near infrared spectral range.
- 1 July 2018
- Published by Elsevier in Journal of Food Composition and Analysis
- Vol. 70, 114-124
Isoflavones quantification in rainbow trout muscle by QuEChERS tecnique and liquid chromatography coupled with mass spectrometry
- 1 July 2018
- Published by Elsevier in Journal of Food Composition and Analysis
- Vol. 70, 114-124
Isoflavones quantification in rainbow trout muscle by QuEChERS tecnique and liquid chromatography coupled with mass spectrometry